New Zealand’s High Court overturns government restrictions that blocked doctors from writing new prescriptions for puberty blockers for young people with gender dysphoria. The ruling effectively restores access for new patients who meet the court-recognised eligibility conditions, while existing patients and some other groups remain able to access treatment.
The restrictions stem from a regulation introduced in November 2025, creating a tiered system that allowed ongoing prescriptions for those already under care, and continued access for certain medical circumstances, but excluded new patients with gender-related health needs. The High Court found the restrictions were unlawful.
Coverage across outlets focuses on the same central outcome: the ban is overturned and access for new prescriptions is restored. Some reporting highlights the discrimination framing used by the court, while other coverage emphasises the regulatory mechanism—an order recommended by the Health Minister following consultation—and the role of a legal challenge brought by a professional association.
